Drug Profile
Amcipatricin - Kaken Pharmaceutical
Alternative Names: IB 643; SPA S 752; SPA S 753; SPA S 843Latest Information Update: 19 Jan 2011
Price :
$50
*
At a glance
- Originator SPA
- Developer Kaken Pharmaceutical; SPA
- Class Antifungals
- Mechanism of Action Cell membrane permeability enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Mycoses